Find clinical trials for Lung Cancer in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Atlanta, GA, USA:
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Dunwoody, Georgia, United States and 122 other locations
This study is designed to evaluate safety and antitumor activity of HER3-DXd in two parts: Dose Escalation and Dose Expansion.In Dose Escalation, HER...
Phase 1
Atlanta, Georgia, United States and 21 other locations
The main aim of this study is to:evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1] by investiga...
Phase 2
Atlanta, Georgia, United States and 79 other locations
, early-stage non-small cell lung cancer....
Phase 2
Gainesville, Georgia, United States and 94 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Atlanta, Georgia, United States and 157 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...
Phase 2
Lawrenceville, Georgia, United States and 137 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Marietta, Georgia, United States and 181 other locations
This phase I trial aims to determine if it is safe to use palliative radiotherapy and lurbinectedin at the same time to treat small cell lung...
Phase 1
Atlanta, Georgia, United States and 2 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Marietta, Georgia, United States and 227 other locations
a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non Small Cell Lung...
Phase 3
Atlanta, Georgia, United States and 168 other locations
Clinical trials
Research sites
Resources
Legal